UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4098.5

Change

+30.75 (+0.76)%

Market Cap

N/A

Volume

259.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.00 (-1.86%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-7.31 (-5.47%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.31%)

USD 588.35B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.10 (+0.54%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+0.99%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.54%)

USD 260.39B
0QZO:LSE 0QZO

-0.30 (-0.27%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-2.89 (-1.76%)

USD 202.26B
0R24:LSE Intel Corp.

-1.31 (-5.34%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.53% 93% A 86% B+
Dividend Return 0.01% 22% F 20% F
Total Return 11.54% 93% A 85% B
Trailing 12 Months  
Capital Gain 13.61% 69% C- 67% D+
Dividend Return 0.05% 29% F 26% F
Total Return 13.66% 67% D+ 66% D+
Trailing 5 Years  
Capital Gain 35.76% 52% F 62% D
Dividend Return 0.19% 32% F 44% F
Total Return 35.95% 49% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.50% 56% F 61% D-
Dividend Return 8.51% 55% F 61% D-
Total Return 0.00% 18% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 12.20% 59% D- 75% C
Risk Adjusted Return 69.73% 68% D+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.